Cargando…
CD4(+)CD25(+)FOXP3(+) regulatory T cells: a potential “armor” to shield “transplanted allografts” in the war against ischemia reperfusion injury
Despite the advances in therapeutic interventions, solid organ transplantation (SOT) remains the “gold standard” treatment for patients with end-stage organ failure. Recently, vascularized composite allotransplantation (VCA) has reemerged as a feasible treatment option for patients with complex comp...
Autores principales: | Jeyamogan, Shareni, Leventhal, Joseph R., Mathew, James M., Zhang, Zheng Jenny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587564/ https://www.ncbi.nlm.nih.gov/pubmed/37868962 http://dx.doi.org/10.3389/fimmu.2023.1270300 |
Ejemplares similares
-
Foxp3+ regulatory T cell therapy for tolerance in autoimmunity and solid organ transplantation
por: Sanders, Jes M., et al.
Publicado: (2022) -
Protective Effect of CXCR3(+)CD4(+)CD25(+)Foxp3(+) Regulatory T Cells in Renal Ischemia-Reperfusion Injury
por: Jun, Cao, et al.
Publicado: (2015) -
Asiaticoside ameliorates renal ischemia/reperfusion injury by promoting CD4(+)CD25(+)FOXP3(+) treg cell differentiation
por: Tang, Shengjie, et al.
Publicado: (2023) -
The control of CD4(+)CD25(+)Foxp3(+ )regulatory T cell survival
por: Pandiyan, Pushpa, et al.
Publicado: (2008) -
Androgen receptor modulates Foxp3 expression in CD4(+)CD25(+)Foxp3(+) regulatory T-cells
por: Walecki, Magdalena, et al.
Publicado: (2015)